Resource Center

Listen to Katherine R. Tuttle, MD, FASN, FACP, FNKF, Anthony Good, DNP, MBA, FNP-BC, GNP-BC, andJoshua J. Neumiller, PharmD, CDCES, FASCP, FADCES discuss the prevalence of heart failure, chronic kidney disease, type 2 diabetes and the impact these conditions have on patient outcomes. Management options to mitigate these risks, current guidelines and diagnostic practices will also be discussed.

Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes,strategies to assess its risk, and the COORDINATE study.

Listen to Michael J. Blaha, MD, MPH and Richard E. Pratley, MD discuss the link between type 2 diabetes and chronic kidney disease (CKD) as well as taking a multidisciplinary approach to managing people with type 2 diabetes at risk for chronic kidney disease progression.

Listen to Traci Thompson, MD, MBA, CPE, Latha Palaniappan, MD, MS, and Alka Kanaya, MD discuss racial and ethnic considerations when screening and managing patients with type 2 diabetes (T2D) and cardiovascular disease (CVD), as well as related health care disparities and barriers in managing and treating T2D and CVD.

Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes.

Help patients with diabetes manage their risk for heart disease and stroke. Donald Lloyd-Jones, MD, ScM, FAHA, FACC and Jane EB Reusch, MD, FAHA discuss the recent release of AHA’s Life’s Essential 8...

Diabetes is more than a blood sugar problem. Help your patients with type 2 diabetes understand their risk of cardiovascular disease and the importance of blood pressure, lipid, and glucose control in managing risk.

Listen to Eduardo Sanchez, MD, MPH, FAHA and Robert A. Gabbay, MD, PhD give an update on the Know Diabetes by Heart™ initiative from launch through 2021 including notable insights, key learnings and future outlook as well as empowering patients to be active members of their health care team.

Listen to George L. Bakris, MD, FAHA, FASN, Cecilia C. Low Wang, MD, FACP and Neda Rasouli, MD educate clinicians on the updates made in the 2021 ADA Standards of Care related to metformin use and considerations for when the guideline recommends considering use of SGLT-2 inhibitors and GLP-1 receptor agonists independent of A1C or metformin use.

Listen to Dr. Boris Draznin, an endocrinologist and specialist in diabetes and internal medicine, and Dr. Pam Kushner, a specialist in family medicine discuss how the new American Diabetes Association’s 2021 Standards of Care have changed and implications for practice.